Posted by on January 26, 2018 10:54 am
Categories: Uncategorized

Porteus himself is working with FDA to start clinical trials of a Crispr-based therapy for sickle cell disease. The key difference between Crispr and more traditional gene therapy, he said, is in its precision. The original version of gene therapy …Read more

Leave a Reply